VANGUARD GROUP INC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$181,513,000
+1.0%
14,591,103
+11.1%
0.01%
-9.1%
Q3 2016$179,737,000
+91.1%
13,129,074
+3.2%
0.01%
+83.3%
Q2 2016$94,033,000
+18.1%
12,724,399
+2.1%
0.01%
+20.0%
Q1 2016$79,653,000
+4.9%
12,465,396
+2.6%
0.01%0.0%
Q4 2015$75,912,000
-84.7%
12,145,786
-63.2%
0.01%
-73.7%
Q3 2015$497,586,000
+421.5%
32,975,494
+185.8%
0.02%
+216.7%
Q2 2015$95,419,000
+3.6%
11,537,938
+3.3%
0.01%0.0%
Q1 2015$92,071,000
+24.8%
11,173,568
+4.1%
0.01%
+20.0%
Q4 2014$73,757,000
+30.9%
10,735,985
+2.9%
0.01%
+25.0%
Q3 2014$56,353,000
-17.0%
10,435,719
-2.1%
0.00%
-20.0%
Q2 2014$67,878,000
-18.9%
10,655,939
+2.6%
0.01%
-28.6%
Q1 2014$83,699,000
+18.7%
10,384,378
+0.5%
0.01%
+16.7%
Q4 2013$70,492,000
-61.5%
10,335,936
+3.8%
0.01%
-66.7%
Q3 2013$183,198,000
+8.1%
9,956,395
+2.7%
0.02%0.0%
Q2 2013$169,484,0009,690,3450.02%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$82,111,00018.09%
Consonance Capital Management LP 5,575,742$35,629,0005.39%
Opaleye Management Inc. 1,250,000$7,988,0004.98%
Tamarack Advisers, LP 1,600,000$10,224,0003.58%
Camber Capital Management LP 5,405,235$34,539,0002.02%
IRONWOOD INVESTMENT MANAGEMENT LLC 324,636$2,074,0001.36%
Palo Alto Investors LP 2,248,317$14,367,0001.12%
1492 Capital Management LLC 202,500$1,294,0001.09%
Geduld E E 120,100$767,0001.05%
JS Capital Management LLC 868,700$5,551,0001.00%
View complete list of ARIAD PHARMACEUTICALS INC shareholders